Company Filing History:
1 out of 4,770 
1 out of 2,405 
1 out of 47 
Years Active: 2008-2011
Title: Koji Yamada: Innovator in Therapeutic Agents
Introduction
Koji Yamada is a notable inventor based in Tsuchiura, Japan. He has made significant contributions to the field of therapeutic agents, particularly through his innovative work on spirochromanone derivatives. With a total of 2 patents, Yamada's inventions focus on addressing various ACC-related disorders.
Latest Patents
Yamada's latest patents include the development of spirochromanone derivatives as acetyl coenzyme A carboxylase (ACC) inhibitors. The first patent relates to a compound of a specific formula, which is useful as a therapeutic agent for various ACC-related disorders. The second patent also involves spirochromanone derivatives, emphasizing their potential as effective therapeutic agents.
Career Highlights
Throughout his career, Koji Yamada has worked with prominent companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in the pharmaceutical field and has facilitated his innovative research.
Collaborations
Yamada has collaborated with notable coworkers, including Takeru Yamakawa and Hideki Jona. These partnerships have likely enhanced his research and development efforts in creating effective therapeutic solutions.
Conclusion
Koji Yamada's contributions to the field of therapeutic agents through his innovative patents highlight his role as a significant inventor. His work continues to impact the treatment of ACC-related disorders, showcasing the importance of innovation in healthcare.